Standout Papers

Brigatinib in Patients With Crizotinib-Refractory Anaplastic Ly... 2012 2026 2016 2021 599
  1. Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase–Positive Non–Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial (2017)
    Dong‐Wan Kim, Marcello Tiseo et al. Journal of Clinical Oncology
  2. Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non–Small-Cell Lung Cancer: The Phase III POSEIDON Study (2022)
    Melissa L. Johnson, Byoung Chul Cho et al. Journal of Clinical Oncology
  3. Treatment Outcomes and Safety of Mobocertinib in Platinum-Pretreated Patients With EGFR Exon 20 Insertion–Positive Metastatic Non–Small Cell Lung Cancer (2021)
    Caicun Zhou, Suresh S. Ramalingam et al. JAMA Oncology
  4. First-SIGNAL: First-Line Single-Agent Iressa Versus Gemcitabine and Cisplatin Trial in Never-Smokers With Adenocarcinoma of the Lung (2012)
    Ji‐Youn Han, Keunchil Park et al. Journal of Clinical Oncology
  5. Osimertinib + Savolitinib to Overcome Acquired MET-Mediated Resistance in Epidermal Growth Factor Receptor–Mutated, MET -Amplified Non–Small Cell Lung Cancer: TATTON (2022)
    Ryan J. Hartmaier, Aleksandra Markovets et al. Cancer Discovery

Immediate Impact

2 by Nobel laureates 10 from Science/Nature 74 standout
Sub-graph 1 of 16

Citing Papers

Transferrin receptor targeting chimeras for membrane protein degradation
2024 StandoutNature
Natural killer cell therapies
2024 StandoutNature
2 intermediate papers

Works of Sang‐We Kim being referenced

Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non–Small-Cell Lung Cancer: The Phase III POSEIDON Study
2022 Standout
MA08.03 Osimertinib vs Platinum-Pemetrexed for T790M-Mutation Positive Advanced NSCLC (AURA3): Plasma ctDNA Analysis
2017
and 1 more

Author Peers

Author Last Decade Papers Cites
Sang‐We Kim 3816 3402 1370 206 5.3k
Jong Seok Lee 3538 3287 1084 144 5.1k
Lowell L. Hart 2166 3433 1702 125 5.4k
Thomas E. Stinchcombe 3619 3751 1698 212 6.7k
Hiroshi Nokihara 3287 3801 1635 236 5.8k
Nick Thatcher 3888 3932 1472 114 5.6k
Purvish M. Parikh 2541 2538 910 147 4.2k
Wallace Akerley 3090 2661 1063 156 5.1k
Philip Bonomi 4349 4803 2075 240 7.8k
Hyo Sup Shim 2987 2305 1481 159 5.0k
Rogério Lilenbaum 5344 5515 2115 105 8.3k

All Works

Loading papers...

Rankless by CCL
2026